Tag: MitraClip

EXPAND registry outcomes of new MitraClip devices in line with COAPT

 Jörg Hausleiter (Munich, Germany) talks to Cardiovascular News about the one-year findings of ...
MitraClip in moderate surgical risk patients

Virtual ACC: Newer generations of MitraClip associated with greater reduction in mitral regurgitation than previous version

Today at the American College of Cardiology/World Congress of Cardiology’s virtual scientific se...

Abbott gets green light for trial on MitraClip in moderate surgical risk patients

Abbott has announced that the US Food and Drug Administration (FDA) has approved a first-of-its-...

TCT 2019: COAPT finds MitraClip safety and efficacy is maintained at three years, and is cost-effective

The MitraClip device (Abbott) continues to demonstrate safety and efficacy at three years in pat...

ESC 2019: Two-year findings of MITRA-FR continue to show no prognosis benefit with MitraClip

At the European Society of Cardiology Congress (ESC 2019; 31 August–4 September, Paris, France),...

Fourth-generation MitraClip receives FDA approval

According to a statement, Abbott has announced it has received US Food and Drug Administration (...

PASCAL poised to rival MitraClip for safety and efficacy

PASCAL’s (Edwards Lifesciences) safety and efficacy may rival that of MitraClip (Abbott) for the...
MitraClip in moderate surgical risk patients

MitraClip can be used to treat secondary mitral regurgitation in the USA

The US FDA has approved a new indication for percutaneous edge-to-edge repair (MitraClip, Abbott...
MitraClip in moderate surgical risk patients

Draft NICE guidance supports use of percutaneous mitral valve repair

In draft recommendations, England’s National Institute for Health and Care Excellence (NICE) giv...

TCT 2018: Durable tricuspid regurgitation reduction with MitraClip

Data from the TriValve Registry—an international multicentre, retrospective, multidevice, regist...

TCT 2018: Audience claps as COAPT shows MitraClip reduces HF hospitalisations

Delegates at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21-25 September, ...

ESC 2018: MitraClip makes “absolutely no difference” for the prognosis of secondary mitral valve regurgitation

The first randomised controlled trial to compare percutaneous edge-to-edge repair (MitraClip, Ab...
MitraClip in moderate surgical risk patients

Next-generation of MitraClip approved for use in the USA

Abbott has received approval from the US FDA for a next-generation version of its MitraClip hear...

Location of tricuspid regurgitation predicts procedural success of percutaneous edge-to-edge repair

Supporting the results of previous studies, a new study indicates that percutaneous edge-to-edge...

MitraClip becomes first approved device for transcatheter mitral valve repair in Japan

Abbott has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved its...

Millipede 50mm annuloplasty ring used in first cases

Millipede has announced the successful implantation of its newest 50mm Iris annuloplasty ring, w...

Combining MitraClip mitral valve repair with left atrial appendage occlusion is safe and feasible

Shingo Kuwata (University Heart Center, Zurich, Switzerland) and others report in Eurointerventi...

PCRLV 2016: MitraClip may be “safe and feasible” for treating tricuspid regurgitation

A first-in-man study indicates that percutaneous edge-to-edge repair with Abbott Vascular’s Mitr...